Funded Biotechnology Startups in Charlottesville
Charlottesville, Virginia has produced a measurable cluster of biotechnology funding activity across these 10 records, spanning May 2022 through November 2…
Charlottesville, Virginia has produced a measurable cluster of biotechnology funding activity across these 10 records, spanning May 2022 through November 2023. Round sizes vary considerably — Rivus Pharmaceuticals closed a $132M Series B in September 2022 at the high end, while Transfoam received a $20K grant in May 2022 and Ourobio raised a $150K pre-seed in August 2022.
The bulk of more recent rounds, including HemoShear Therapeutics ($4M, November 2023), AMPEL BioSolutions ($2M, July 2023), and Adial Pharmaceuticals ($750K, February 2023), are classified as Series Unknown — a label that often reflects SAFE notes, convertible instruments, or rounds where structure was not publicly disclosed. Contraline's $7M Series A in November 2022 and Atelerix Life Sciences' $650K seed in October 2022 sit in the mid-range. CvilleBioHub's $200K round in August 2023 adds to the concentration of smaller activity within the city.
Most recent rounds
10 shownRelated listings
Frequently asked
What is the largest disclosed round among these Charlottesville biotech companies?
Rivus Pharmaceuticals raised $132M in a Series B closed September 22, 2022 — by a wide margin the largest disclosed amount in this set. The next largest is Contraline's $7M Series A from November 2022.
What round stages are most common in this group?
Five of the ten rounds are classified as Series Unknown, which typically covers SAFEs, convertible notes, or rounds where structure was not publicly disclosed. The remaining five span pre-seed (Ourobio), seed (Atelerix Life Sciences), Series A (Contraline), Series B (Rivus Pharmaceuticals), and a grant (Transfoam).
How recent is the latest funding activity shown?
The most recent record is HemoShear Therapeutics, which raised $4M in November 2023. CvilleBioHub ($200K) and AMPEL BioSolutions ($2M) both closed rounds in mid-2023, indicating continued activity through at least Q3 2023.
Which companies have undisclosed round amounts?
PS Fertility's Series Unknown round from June 2023 is the only record in this set where the amount was not reported. All other nine companies have a disclosed figure, ranging from $20K to $132M.
Which companies are at the earliest funding stages?
Ourobio raised a $150K pre-seed in August 2022, and Transfoam received a $20K grant in May 2022 — both represent the earliest-stage activity in this group. Atelerix Life Sciences closed a $650K seed round in October 2022, making it the next earliest by stage.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.